ClinicalTrials.gg
RecruitingNCT07764029Updated Aug 14, 2026

Efficacy of PRF and Xenograft in Treating Mandibular Molar Furcation Involvements

An interventional study of A-PRF+ and Xenograft and Collagen Membrane and Xenograft in Periodontitis and Furcation Defects, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Recruiting at 1 site in Vietnam. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this randomized controlled clinical trial is to compare the effectiveness of advanced platelet-rich fibrin (A-PRF+) combined with xenograft versus a collagen membrane combined with xenograft in the treatment of degree II furcation involvements in mandibular first molars. Adult patients with periodontitis will randomly receive either the A-PRF+ treatment or the collagen membrane treatment during periodontal flap surgery. The study will evaluate clinical periodontal healing, bone regeneration using 3D imaging (CBCT), patient comfort (pain levels and satisfaction), and changes in the TWEAK biomarker in gingival crevicular fluid over a 6-month period.

Read the detailed description

Furcation involvements in molars pose a significant challenge in periodontal therapy. This study aims to evaluate a regenerative approach using advanced platelet-rich fibrin (A-PRF+) to enhance clinical and radiographic outcomes. The study includes adult patients with periodontitis who have a degree II furcation involvement (Hamp 1975) on a mandibular molar, with a probing pocket depth of ≥ 5mm after initial non-surgical therapy.

Eligible patients will be randomly allocated to one of two surgical interventions:

Test Group: Open flap debridement followed by the application of A-PRF+ mixed with a xenograft (Cerabone), covered by an A-PRF+ membrane.

Control Group: Open flap debridement followed by the application of a xenograft (Cerabone) covered by a resorbable collagen membrane (Guided Tissue Regeneration).

Clinical parameters including Plaque Index (PlI), Gingival Index (GI), Probing Pocket Depth (PPD), Gingival Recession (GR), Vertical Clinical Attachment Level (VCAL), and Horizontal Clinical Attachment Level (HCAL) will be recorded at baseline and 6 months post-surgery using customized acrylic stents.

Radiological assessments using Cone Beam Computed Tomography (CBCT) will measure furcation volume, bone fill, and new bone gray level at baseline and 6 months. Patient-reported outcomes, including pain perception (VAS), painkiller consumption, and post-operative satisfaction (Likert scale), will be monitored during the first week. Additionally, Gingival Crevicular Fluid (GCF) samples will be collected to analyze the concentration of the TWEAK biomarker via ELISA at baseline, 1 month, and 3 months post-surgery.

02

Conditions studied

  • Periodontitis
  • Furcation Defects

Keywords

  • A-PRF plus
  • A-PRF+
  • Xenograft
  • Mandibular Molar
  • Guided Tissue Regeneration
  • TWEAK
  • biomarker
  • collagen membrane
03

In context

Periodontitis

1,231 studies on the registry are indexed under Periodontitis; 295 are open to participants now.

This study's planned enrollment of 22 is below the median of 44 across 846 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 127 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients over 18 years old
  • Patients diagnosed with periodontitis who have completed non-surgical treatment: scaling and root planing
  • Patients attending a follow-up visit at least 5 weeks after non-surgical treatment, demonstrating compliance and good oral hygiene cooperation
  • Presence of a mandibular molar with a Degree II furcation involvement according to Hamp (1975), presenting a residual periodontal pocket at the buccal site (PPD ≥ 5mm) after non-surgical treatment, and showing radiolucency in the furcation area on CBCT imaging
  • Plaque Index (PlI) \< 1 following non-surgical treatment
  • Width of keratinized gingiva ≥ 2mm
  • Teeth with furcation defects where gingival recession does not extend apically beyond the buccal furcation fornix (no supragingival furcation exposure)
  • Teeth without occlusal trauma, pulpal or periapical pathologies, and no combined periodontic-endodontic lesions
  • Degree II furcation involvement according to Hamp (1975) and Subclass A or B according to Tarnow and Fletcher (1984)
  • The defect is located apical to the interproximal alveolar bone crest on CBCT imaging

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic diseases affecting periodontal treatment outcomes, such as: diabetes mellitus, heart disease requiring anticoagulant therapy, blood disorders, immunodeficiency, etc
  • Pregnant or lactating patients
  • Patients who have used antibiotics or any other medications affecting periodontal treatment outcomes within the last 6 months
  • Patients who smoke tobacco.
  • Patients who have used aspirin or medications affecting blood coagulation within 2 weeks prior to the blood collection for PRF preparation
  • Patients with a history of allergy to local anesthetics
  • Defects associated with grade II tooth mobility that has not been splinted, or grade III tooth mobility according to Miller (2014)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
22 participants (estimated)

Study arms

  • Experimental
    A-PRF+ and Xenograft

    Open flap debridement followed by the application of A-PRF+ mixed with xenograft (Cerabone), covered by an A-PRF+ membrane

    Procedure: A-PRF+ and Xenograft

  • Active comparator
    Collagen Membrane and Xenograft

    Open flap debridement followed by the application of xenograft (Cerabone) covered by a resorbable collagen membrane

    Procedure: Collagen Membrane and Xenograft

Interventions

  • ProcedureA-PRF+ and Xenograft

    Open flap debridement surgery. The furcation defect is filled with a mixture of A-PRF+ fragments and bovine xenograft (Cerabone), and then covered with an A-PRF+ membrane before suturing

    Also known as: Advanced Platelet-Rich Fibrin plus, Cerabone, A-PRF+

  • ProcedureCollagen Membrane and Xenograft

    Open flap debridement surgery. The furcation defect is filled with bovine xenograft (Cerabone) and covered with a resorbable collagen membrane before suturing

    Also known as: Guided Tissue Regeneration, Bio-Gide, Cerabone, Collagen membrane

06

What researchers measure

Primary outcomes

  1. Horizontal Clinical Attachment Level (HCAL)

    HCAL is evaluated using a Nabers probe and a customized acrylic stent to measure the horizontal penetration from the buccal furcation entrance to the deepest point of the defect

    Time frame: Baseline and 6 months post-surgery

  2. Probing Pocket Depth (PPD)

    PPD is measured using a UNC-15 periodontal probe and a customized acrylic stent to ensure measurement reproducibility. The measurement is recorded at the buccal aspect of the involved tooth

    Time frame: Baseline and 6 months post-surgery

Secondary outcomes

  1. Plaque Index (PlI)

    Assessed at 4 sites per tooth using the Loe and Silness (1963) criteria

    Time frame: Baseline, 3 months, and 6 months post-surgery

  2. Gingival Index (GI)

    Assessed using the Loe and Silness (1963) criteria to evaluate gingival inflammation

    Time frame: Baseline and 6 months post-surgery

  3. Vertical Clinical Attachment Level (VCAL)

    Measured using a UNC-15 periodontal probe and a customized acrylic stent

    Time frame: Baseline and 6 months post-surgery

  4. Gingival Recession (GR)

    Evaluated using a 3D intraoral scanner (3Shape TRIOS) and a customized acrylic stent

    Time frame: Baseline, 3 months, and 6 months post-surgery

  5. Radiographic Vertical Bone Level (VBL)

    Measured on Cone Beam Computed Tomography (CBCT) images from the furcation fornix to the base of the defect

    Time frame: Baseline and 6 months post-surgery

  6. Furcation Defect Volume

    Evaluated using CBCT images and 3D segmentation software (ITK-SNAP)

    Time frame: Baseline and 6 months post-surgery

  7. New Bone Gray Level

    Evaluated using CBCT and ImageJ software to assess the density of newly formed bone

    Time frame: Baseline and 6 months post-surgery

  8. TWEAK Biomarker Concentration

    Measured in Gingival Crevicular Fluid (GCF) using Enzyme-Linked Immunosorbent Assay (ELISA)

    Time frame: Baseline, 1 month, and 3 months post-surgery

  9. Post-operative Pain Perception

    Assessed using a 10-cm Visual Analog Scale (VAS) where 0 indicates "no pain" and 10 indicates "worst imaginable pain"

    Time frame: 12 hours, 1 day, and 3 days post-surgery

  10. Post-operative Painkiller Consumption

    Recorded as the total number of analgesic tablets consumed by the patient

    Time frame: Up to 3 days post-surgery

  11. Post-operative Patient Satisfaction

    Evaluated using a 5-point Likert scale (from 1 = very dissatisfied to 5 = very satisfied) regarding post-operative swelling and chewing ability

    Time frame: 3 days and 7 days post-surgery

07

Study locations

1 of 1 sites recruiting
  • Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
    Ho Chi Minh City, Ho Chi Minh City (HCMC) 700000, Vietnam
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07764029
Responsible party
Thanh Si Ho (Doctor of Dental Surgery, University of Medicine and Pharmacy at Ho Chi Minh City) — Principal investigator
First posted
Aug 13, 2026
Start date
Jun 25, 2026
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Aug 14, 2026

Study contacts

Thanh Si Ho, Doctor of Dental Surgery
Contact
sithanhlk2000@gmail.com
+84944510521

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion